Evidence map›Paper›PMID 26609141›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2016

Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro.

Alejandro M S Mayer, Joseph Murphy, David MacAdam, Christopher Osterbauer, Imaan Baseer, Mary L Hall, Domonkos Feher, Phillip Williams

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Role of CXCL10 in Spinal Cord Injury.International journal of medical sciences · 2022
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Microglia: Housekeeper of the Central Nervous System.Cellular and molecular neurobiology · 2018
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alejandro M S Mayer*Department of Pharmacology, Chicago College of Osteopathic Medicine and amayer@midwestern.edu.
Joseph MurphyBiomedical Sciences Program, College of Health Sciences, Midwestern University, Downers Grove, Illinois 60515; and.
David MacAdamBiomedical Sciences Program, College of Health Sciences, Midwestern University, Downers Grove, Illinois 60515; and.
Christopher OsterbauerBiomedical Sciences Program, College of Health Sciences, Midwestern University, Downers Grove, Illinois 60515; and.
Imaan BaseerBiomedical Sciences Program, College of Health Sciences, Midwestern University, Downers Grove, Illinois 60515; and.
Mary L Hall*Department of Pharmacology, Chicago College of Osteopathic Medicine and.
Domonkos FeherDepartment of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96882.
Phillip WilliamsDepartment of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96882.
Midwestern University · USUniversity of Hawaiʻi at Mānoa · US

Funding

Capture the Inhibitor: Affinity Approaches to the Discovery of Secretase LeadsR01AG039468 · NIA · UNIVERSITY OF HAWAII AT MANOA · PI WILLIAMS, PHILIP · 2011 to 2014
$1.1M
NIA NIH HHS 1R01AG039468NIA NIH HHS R01 AG039468
6 · The paper itself

Abstract

The purpose of this investigation was to test the hypothesis that an in vitro exposure to cyanobacterium Oscillatoria sp. Lipopolysaccharide (LPS) might result in classical and alternative activation of rat neonatal microglia. Using Escherichia coli LPS-primed microglia as a positive control, this study revealed that treatment of rat microglia with Oscillatoria sp. LPS for 17 h in vitro resulted in both classical and alternative activation as well as concomitant pro-inflammatory and anti-inflammatory mediator release, in a concentration-dependent manner: (1) treatment with 0.1-10 000 ng/ml Oscillatoria sp. LPS resulted in minimal lactic dehydrogenase (LDH) release, induced concentration-dependent and statistically significant O2 (-) generation, matrix metalloproteinase-9 (MMP-9) release, generation of the cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and the chemokines macrophage inflammatory protein-2 (MIP-2/CXCL2), interferon γ-induced protein 10 kDa (IP-10/CXCL-10), (MIP-1α/CCL3), monocyte chemotactic protein-1 (MCP-1/CCL2), regulated on activation, normal T cell expressed and secreted (RANTES/CCL5), and the alternative activation cytokine IL-10; (3) in contrast, treatment with 100 000 ng/ml Oscillatoria sp. LPS appeared to damage the microglia cell membrane, because it resulted in minimal O2 (-) generation, statistically significant LDH release, and a decrease in the generation of all the cytokines and chemokines investigated, with the exception of IL-1α and cytokine-induced neutrophil chemoattractant 1 (CINC-1/CXCL1) generation, which was increased. Thus, our results provide experimental support for our working hypothesis, namely that Oscillatoria sp. LPS induces classical and alternative activation of rat brain microglia in vitro in a concentration-dependent manner, namely 0.1-10 000 ng/ml Oscillatoria sp. LPS, when microglia cells were shown to be viable. Furthermore, should cyanobacterium Oscillatoria sp. LPS gain entry into the CNS, our findings suggest that classical and alternative activation of rat brain microglia in vivo, might lead to concomitant mediator release that could result in an interplay between neuroinflammation and neural repair in a concentration-dependent manner.

Indexed as

AnimalsChemokinesCytokinesIn Vitro TechniquesLipopolysaccharidesL-Lactate DehydrogenaseMatrix Metalloproteinase 2Matrix Metalloproteinase 9MicrogliaOscillatoriaRatsRats, Sprague-DawleySuperoxidesThromboxane B2ChemokinesCytokinesLipopolysaccharidesL-Lactate DehydrogenaseMatrix Metalloproteinase 2Matrix Metalloproteinase 9SuperoxidesThromboxane B2alternative activationclassical activationcyanobacterialipopolysaccharidemicrogliaOscillatoriarat

Identifiers

PMID26609141
PMCPMC4900220
OpenAlexW2247620173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.